7S4

N-{(1R)-1-[N''-cyano-N'-(quinolin-5-yl)carbamimidamido]-2,2-dimethylpropyl}-2-(3,4-dimethoxyphenyl)acetamide

Created:	2016-12-02
Last modified:	2021-03-01

Find Related PDB Entry
1 entries where 7S4 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	65
Chiral Atom Count	1
Bond Count	67
Aromatic Bond Count	17

2D diagram of 7S4

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-{(1R)-1-[N''-cyano-N'-(quinolin-5-yl)carbamimidamido]-2,2-dimethylpropyl}-2-(3,4-dimethoxyphenyl)acetamide
Synonyms	antagonist A740003
Systematic Name (OpenEye OEToolkits)	~{N}-[(1~{R})-1-[[(~{Z})-~{N}'-cyano-~{N}-quinolin-5-yl-carbamimidoyl]amino]-2,2-dimethyl-propyl]-2-(3,4-dimethoxyphenyl)ethanamide
Formula	C₂₆ H₃₀ N₆ O₃
Molecular Weight	474.555
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	c1(cc(c(OC)cc1)OC)CC(NC(C(C)(C)C)N\C(=N/C#N)Nc2cccc3c2cccn3)=O
SMILES	CACTVS	3.385	COc1ccc(CC(=O)N[CH](NC(Nc2cccc3ncccc23)=NC#N)C(C)(C)C)cc1OC
SMILES	OpenEye OEToolkits	2.0.6	CC(C)(C)C(NC(=O)Cc1ccc(c(c1)OC)OC)NC(=NC#N)Nc2cccc3c2cccn3
Canonical SMILES	CACTVS	3.385	COc1ccc(CC(=O)N[C@@H](NC(Nc2cccc3ncccc23)=NC#N)C(C)(C)C)cc1OC
Canonical SMILES	OpenEye OEToolkits	2.0.6	CC(C)(C)[C@@H](NC(=O)Cc1ccc(c(c1)OC)OC)N/C(=N\C#N)/Nc2cccc3c2cccn3
InChI	InChI	1.03	InChI=1S/C26H30N6O3/c1-26(2,3)24(31-23(33)15-17-11-12-21(34-4)22(14-17)35-5)32-25(29-16-27)30-20-10-6-9-19-18(20)8-7-13-28-19/h6-14,24H,15H2,1-5H3,(H,31,33)(H2,29,30,32)/t24-/m0/s1
InChIKey	InChI	1.03	PUHSRMSFDASMAE-DEOSSOPVSA-N

Related Resource References

Resource Name	Reference
PubChem	76967808, 98050091, 137348663

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.